Envoy Medical, Inc.
COCHNASDAQHealthcare● Active
$0.66
$-0.00(-0.33%)
Market Cap$13707200
P/E Ratio—
52W High$1.89
52W Low$0.363
Envoy Medical, Inc. (COCH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · COCH · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.24M | $0.23M | $0.32M | $0.24M | $0.31M |
| Cost of Revenue | $0.87M | $0.74M | $0.79M | $0.50M | $0.77M |
| Gross Profit | ($0.63M) | ($0.52M) | ($0.47M) | ($0.26M) | ($0.46M) |
| Gross Margin %(computed) | -262.66% | -229.78% | -149.68% | -110.13% | -148.06% |
| Operating Expenses | |||||
| R&D Expenses | $12.49M | $10.18M | $8.96M | $4.97M | $3.94M |
| G&A Expenses | $7.93M | $6.83M | $7.26M | $2.58M | $2.47M |
| Total Operating Expenses | $21.64M | $18.74M | $17.89M | $8.45M | $6.41M |
| Operating Income | ($22.27M) | ($19.26M) | ($18.36M) | ($8.71M) | ($6.87M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.04M |
| Interest Expense | $1.59M | $0.82M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($23.76M) | ($20.80M) | ($29.92M) | ($15.92M) | ($8.68M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($23.76M) | ($20.80M) | ($29.92M) | ($15.92M) | ($8.68M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.23 | $-1.49 | $-2.54 | $-1.57 | $-1.05 |
| Wtd Avg Shares | 19.60M | 18.79M | 12.55M | 10.15M | 10.15M |
| EBITDA | ($21.97M) | ($19.81M) | ($29.79M) | ($8.63M) | ($6.80M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Envoy Medical, Inc. data
About Envoy Medical, Inc. (COCH) Income Statement
Envoy Medical, Inc. (COCH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, COCH reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -262.66%), and net income of ($0.02B) — a net profit margin of -9857.26%.
Frequently asked questions
COCH · 4 questionsEnvoy Medical, Inc. (COCH) reported revenue of $0.00B for 2025, up 7.1% year-over-year.
COCH revenueCOCH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09